These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 7656834)
1. [Lipoprotein(a) and hemostasis activation markers in angina pectoris]. Tsakiris DA; Riesen WF; Marbet GA Dtsch Med Wochenschr; 1995 Aug; 120(33):1109-13. PubMed ID: 7656834 [TBL] [Abstract][Full Text] [Related]
2. Hemostasis activation markers in acute renal failure. Stefanidis I; Frank D; Maurin N Ren Fail; 1998 Jan; 20(1):147-55. PubMed ID: 9509568 [TBL] [Abstract][Full Text] [Related]
3. Absence of a prothrombotic state in restenotic patients? Brack MJ; More RS; Pringle S; Gershlick AH Coron Artery Dis; 1994 Jun; 5(6):501-6. PubMed ID: 7952409 [TBL] [Abstract][Full Text] [Related]
4. The molecular markers of hemostatic activation on coronary artery disease. Ulutin T; Sönmez H; Uçişik N; Süer S; Bayram C; Kökoglu E; Sultuybek G Thromb Res; 1997 Nov; 88(3):329-32. PubMed ID: 9526953 [TBL] [Abstract][Full Text] [Related]
5. Fibrinopeptide A and platelet factor levels in unstable angina pectoris. Théroux P; Latour JG; Léger-Gauthier C; De Lara J Circulation; 1987 Jan; 75(1):156-62. PubMed ID: 2947740 [TBL] [Abstract][Full Text] [Related]
6. Fibrinopeptide A and beta thromboglobulin in patients with angina pectoris and acute myocardial infarction. van Hulsteijn H; Kolff J; Briët E; van der Laarse A; Bertina R Am Heart J; 1984 Jan; 107(1):39-45. PubMed ID: 6197872 [TBL] [Abstract][Full Text] [Related]
7. Biological risk factors for restenosis after percutaneous transluminal coronary angioplasty. Benchimol D; Bonnet J; Benchimol H; Drouillet F; Duplaa C; Couffinhal T; Desgranges C; Bricaud H Int J Cardiol; 1993 Jan; 38(1):7-18. PubMed ID: 8444504 [TBL] [Abstract][Full Text] [Related]
8. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Thompson SG; Kienast J; Pyke SD; Haverkate F; van de Loo JC N Engl J Med; 1995 Mar; 332(10):635-41. PubMed ID: 7845427 [TBL] [Abstract][Full Text] [Related]
10. Plasmatic markers of haemostatic system activation in patients with solid neoplasms. Sagripanti A; Carpi A; Ferdeghini M; Baicchi U; Grassi B J Nucl Med Allied Sci; 1990; 34(4):321-32. PubMed ID: 2151044 [No Abstract] [Full Text] [Related]
11. Changes of hemostasis, endogenous fibrinolysis, platelet activation and endothelins after percutaneous transluminal coronary angioplasty in patients with stable angina. Borries M; Heins M; Fischer Y; Stiegler H; Peters A; Reinauer H; Schoebel FC; Strauer BE; Leschke M J Am Coll Cardiol; 1999 Aug; 34(2):486-93. PubMed ID: 10440163 [TBL] [Abstract][Full Text] [Related]
12. Prothrombin activation fragment 1 + 2 and thrombin antithrombin III complexes in patients with angina pectoris: relation to the presence and severity of coronary atherosclerosis. Kienast J; Thompson SG; Raskino C; Pelzer H; Fechtrup C; Ostermann H; van de Loo J Thromb Haemost; 1993 Oct; 70(4):550-3. PubMed ID: 8115978 [TBL] [Abstract][Full Text] [Related]
13. [Significance of the thrombin-antithrombin III complex in the diagnosis of pulmonary embolism and deep venous thrombosis--comparison with fibrinopeptide A, platelet factor 4 and beta-thromboglobulin]. Blanke H; Praetorius G; Leschke M; Seitz R; Egbring R; Strauer BE Klin Wochenschr; 1987 Aug; 65(16):757-63. PubMed ID: 2958657 [TBL] [Abstract][Full Text] [Related]
14. Haemostatic variables in patients with unstable angina. al-Nozha M; Gader AM; al-Momen AK; Noah MS; Jawaid M; Arafa M Int J Cardiol; 1994 Mar; 43(3):269-77. PubMed ID: 8181885 [TBL] [Abstract][Full Text] [Related]
15. Effect of aortic valve stenosis on haemostasis is independent from vascular atherosclerotic burden. Dimitrow PP; Hlawaty M; Undas A; Sniezek-Maciejewska M; Sobień B; Stepień E; Tracz W Atherosclerosis; 2009 Jun; 204(2):e103-8. PubMed ID: 19171341 [TBL] [Abstract][Full Text] [Related]
17. Lack of association between haemostatic variables and the presence or the extent of coronary atherosclerosis. Schmitz-Huebner U; Thompson SG; Balleisen L; Fechtrup C; Grosse-Heitmeyer W; Kirchhof B; Most E; Müller US; Seiffert C; Seiffert D Br Heart J; 1988 Mar; 59(3):287-91. PubMed ID: 3258521 [TBL] [Abstract][Full Text] [Related]
18. The influence of coronary angiography and angioplasty on parameters of hemostasis and fibrinolysis. Six AJ; Tjon RM; Buys EM; Haas F; Hollander-van Zalk A; Haverkate F Thromb Haemost; 1990 Aug; 64(1):113-6. PubMed ID: 2148844 [TBL] [Abstract][Full Text] [Related]
19. [Changes in antithrombin III, prothrombin fragment 1 + 2 and thrombin-antithrombin III complex following implantation of a coronary Palmaz-Schatz stent]. Dittel M; Haushofer A; Spiel R; Halbmayer WM; Prachar H; Fischer M; Mlczoch J Z Kardiol; 1995 Jan; 84(1):22-9. PubMed ID: 7863710 [TBL] [Abstract][Full Text] [Related]
20. Predictive value of hemostatic factors for sudden death in patients with stable angina pectoris. Benchimol D; Dartigues JF; Benchimol H; Drouillet F; Lauribe P; Marazanof M; Couffinhal T; Bonnet J Am J Cardiol; 1995 Aug; 76(4):241-4. PubMed ID: 7618616 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]